These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Fourth protease inhibitor hits the market.
    Journal: AIDS Alert; 1997 May; 12(5):59-60. PubMed ID: 11364224.
    Abstract:
    Nelfinavir (Viracept) became the fourth protease inhibitor to gain marketing clearance from the Food and Drug Administration (FDA). Approved in mid-March, Viracept will make a contribution to the efforts to treat the virus aggressively soon after diagnosis. Viracept was developed by Agouron, and the retail price of treatment will be $15.48 per day. There is a patient assistance program to help those who are financially unable to pay for the treatment.
    [Abstract] [Full Text] [Related] [New Search]